Oncotelic Therapeutics, Inc.

Public

United StatesHealthcarehttps://www.oncotelic.com/

Oncotelic Therapeutics, Inc. is now publicly traded

The data on this page reflects Oncotelic Therapeutics, Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Grant

Jul 22, 2026

Total Funding Raised

$711,840

Company Overview

Oncotelic Therapeutics, Inc. is a biopharmaceutical company that develops RNA-based, immunotherapy, and targeted therapeutics for the treatment of cancer and other rare diseases.

Sector

Healthcare

AI Layer

Non-AI

Keywords

biopharmaceuticaloncology therapeuticsTGF-beta inhibitorclinical-stage biotechdrug developmentGMP manufacturingvascular disrupting agentsmall molecule drugsprotein-based therapeuticsclinical trialsbiotech CDMOinfectious diseasedrug discoverybiotech

Oncotelic Therapeutics, Inc. Comparables

Compare Oncotelic Therapeutics, Inc. with similar companies based on industry and business-model similarity.

Oncotelic Therapeutics, Inc. comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Oncotelic Therapeutics, Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Jul 22, 2026

View all Funding Rounds

Key People

Founding team and executive leadership

Vuong Trieu

Chairman CEO, Chairman CEO

Executive Team

Oncotelic Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Oncotelic Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersUnited States

Employee Range22

Year Founded1988

Last FundingJul 22, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?